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Introduction
Ovarian cancer is the most lethal gynaecological
malignancy. Most patients present at an advanced stage, as the
symptoms of early stage disease can be vague. The estimation
of cancer burden is valuable to setup priorities for disease
control. The comprehensive global cancer statistics from the
international agency for research on cancer indicate that
gynaecological cancer accounted for 19% of the 5.1 million
estimated new cancer cases among women in the world in
2002. Ovarian cancer accounted for 204, 000 new cases and
125,000 deaths.1 In the western world cancer of the ovary is
the fifth leading cause of cancer death among women.2
Incidence rates are highest in developed countries with rates
exceeding 9 per 100,000.3 In 2007, 4,317 women in United
Kingdom died from ovarian cancer accounting for around 6%
of all female deaths from cancer.4 Ovarian cancer is the fifth
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Abstract
Objective: To identify early warning signs and symptoms of ovarian cancer to create awareness for early
diagnosis and management of the disease. 
Methods: This study was conducted at the department of Gynaecology and Obstetrics, Liaquat National
Hospital, Karachi from 2003 to 2007, having 75 patients. The information collected included age, education, and
self perceived state of socio-economic class, presenting clinical signs and symptoms, basic and specific
laboratory investigations. The disease was staged from I to IV upon surgical staging and the type of cancer was
determined by histopathological examination.
Results: Mean age of the patients was 51 ± 12.3 years. Twenty (52%) patients were uneducated, 17 (22.6%)
were below and remaining 19 (25.3%) were above higher secondary level. Most of the patients belonged to the
middle socioeconomic class. Abdominal pain (57.3%) was the most common presenting symptom followed by
abdominal distension (22.6%), urinary complaints (5.3%), vaginal discharge (2.6%) and postmenopausal
bleeding (12%). More than half (56%) of the patients had stage III-IV disease. On histology, papillary serous
cystic adenocarcinoma was the most common (54%) type followed by mucinious (22%), endometroid (10.6%),
yolk sac (2.6%), dysgerminoma (4%), and adult granulose cell tumour (5.3%).
Conclusion: There are no specific ovarian carcinoma symptoms either in early or late stages to ensure early
diagnosis, but in the age group above 40 years persistent clinical symptoms should always be further
investigated (JPMA 60:260; 2010).
most diagnosed cancer among Canadian women, accounting
for 4% of all new cases. The age standardized world rate of
ovarian cancer in Ontario Canada is (10.7 per 100,000 per
year).5 The age-standardized incidence rate of ovarian cancer
increased from 4.0 to 5.4 per 100,000 women (standard: world
population) in Osaka Japan during the period (1975-1998).6 It
is the most fatal malignancy and the most common cancer of
gynaecological origin in Pakistan. The age standardized world
rate of ovarian cancer in Karachi, Pakistan is (10.2 per
100,000 per year).7 In one study it was the 4th prevalent
cancer in the hospitals of Lahore.8 In contrast, the ovarian
cancer rate in Bombay, India is 7.2 per 100,000 per year.8
The objective of the study was to find early warning
signs and symptoms of ovarian cancer to create awareness for
early diagnosis and management of the disease. 
Methodology
From 2003 to 2007, 75 patients of ovarian cancer
diagnosed for the first time were studied. Patients with
recurrence of ovarian cancer and those with secondary
involvement of the ovaries were excluded.
The study was conducted at the department of
Gynaecology and Obstetrics, Liaquat National Hospital and
Medical College Karachi, a private sector facility. The
information collected included age, education, self perceived
state of socio-economic class, the first presenting clinical
signs and symptoms perceived, basic and specific laboratory
investigations, like Ca125, ultrasound, CT Scan/MRI and IVP
were carried out where necessary, and the results were
recorded on a structured proforma after taking consent from
the patient. The disease was staged from stage I to IV upon
surgical staging and the type of cancer was determined by
histopathological examination. All the 75 patients were
operated and peritoneal washings were taken and debulking
was performed of neoplastic tissue and tissue sample was sent
to the histopathology laboratory where the histopathological
examination confirmed the pathology and type of cancer. 
Data analysis was done through SPSS-10.0. Patients'
age was presented by Mean ± SD. For presentation of
qualitative data variables like presenting sign and symptoms,
socio-economic status, lab findings and histological findings,
frequencies and percentages were computed. Statistical test
was not applicable for this descriptive type case-series. 
Results
Mean age of the patients was 51 ± 12.3 years. Nearly
70 % of the patients presented between the age of 40-70 years.
There were 18.6% patients below 40 years of age and 10%
were above 70 years of age. Regarding educational level, 39
(52%) were uneducated, 17 (22.6%) were below Higher
Secondary level of education and remaining 19 (25%) were
above. Most of the patients (71%) belonged to the middle
socioeconomic class. Majority of the patients complained of
abdominal pain (57.3%) as the first presenting symptom
followed by abdominal distension (22.6%), urinary complaints
eg: (dysuria, frequency of micturition, retention) (5.3%),
vaginal discharge (2.6%) and postmenopausal bleeding (12.
%). Surgical staging was done and more than half (56%) of the
patients were found to be having stage III -IV disease. On
histology, papillary serous cystic adenocarcinoma was found to
be the most common (54%), followed by mucinious 22%,
endometroid (10.6%), yolk sac (2.6%), dysgerminoma (4%),
and adult granulosa cell tumour (5.3%).
Discussion
The findings of our study suggest that ovarian cancer
was rare below age 40 years and above age 70.We found
abdominal pain as the most common symptom followed by
abdominal distension, urinary complaints, vaginal discharge,
and postmenopausal bleeding. A similar study carried out in
Poland9 gave the median age for ovarian cancer to be 54 years
with abdominal pain as the most frequent presenting
complaint similar to what we discovered, followed by
abdominal distension. In their study they stated ovarian cancer
to be rare before age 40 and after age 70 which is a similar
finding in our study. However, a study conducted in Nigeria
(Ibadan),10 stated abdominal distension to be the most
common presenting feature with a higher proportion of
patients presented with advanced stage disease which is
similar to our study. Others also reported abdominal distension
as a common feature in their study.11,12
On histology, papillary serous adenocarcinoma was
the common finding, which was also a feature in other
studies.11,12
It was observed that the majority of the patients
belonged to middle-class socioeconomic status. However, we
found no relation between the stage of disease and the
socioeconomic status of the patient. Brewster H, et al
reported13 higher proportion of deprived class presenting at
advanced stages of the disease.
We found no specific sign or symptom for early stage
or for late stage disease In early as well as in late stage, the
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Table: Sign and symptoms at first presentation according
to the stage of disease.
Stage (n) Pain Distension PMB* Discharge UC*
Stage I (13) 9 (69.2%) 2 (15.3%) 0 2 (15.3% ) _
Stage II (20) 13 (65%) 5 (25%) 1 (5%) _ 1 (5% )
Stage III (26) 13 (50%) 7 (26.9%) 4 (15.3%) _ 2 (7.6%) 
Stage IV(16) 8 (50%) 3 (18.7%) 4 (25%) _ 1 (6.2%) 
Total 75 43 17 9 2 4
Overall 57.3% 22.6% 12% 2.6% 5.3%
*PMB (postmenopausal bleeding)* UC (Urinary complaints).
common symptoms we found were abdominal pain and
distension, but most of the patients present at advanced stage
when nothing fruitful can be done. Screening by Ca 125 levels
and ultrasound can be helpful but it is not always predictive or
a conclusive screening tool. Awareness however can be
helpful to understand the warning signs and symptoms of the
disease which are usually ignored by patients. 
Conclusion
There are no specific ovarian carcinoma symptoms
either in early or late stages to ensure early diagnosis, but in
the age group above 40 years persistent clinical symptoms
should always be further investigated, as majority of the
patients are diagnosed late which leads to a poor prognosis.
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